Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

NCT02564198

Conditions: CNS Malignancies, Central Nervous System Neoplasms, Disease Attributes, +10 more
Locations: Childrens Hospital of Alabama Birmingham, Alabama, United States

Children's Oncology Group Monrovia, California, United States

Childrens Hospital of Orange County Orange, California, United States

University of California, San Francisco San Francisco, California, United States

View all 21 locations

View Trial Details

Completed

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

NCT02761915

Conditions: Cytokine Release Syndrome, Disease Attributes, Inflammation, +16 more
Locations: University College London Institute of Child Health & Great Ormond Street Hospital London, United Kingdom

View Trial Details

Completed

Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer

NCT02674568

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +12 more
Locations: Not specified

View Trial Details

Completed

PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer

NCT04983459

Conditions: Disease Attributes, Genital Diseases, Genital Diseases, Male, +11 more
Locations: Richard Pougnet Brest, France

View Trial Details

Completed

Camrelizumab Combined With Apatinib for Recurrent Resistant GTN

NCT04047017

Conditions: Disease Attributes, Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, +10 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

NCT01094405

Conditions: DNA Virus Infections, Disease Attributes, Epstein-Barr Virus Infections, +18 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

NCT00065260

Conditions: Agranulocytosis, Anemia, Anemia, Aplastic, +17 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase III B in Acute Lymphoblastic Leukemia

NCT03123939

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Novartis Investigative Site Vienna, Austria

Novartis Investigative Site Ghent, Belgium

Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Montreal, Quebec, Canada

View Trial Details

Completed

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

NCT00528437

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +18 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Emory University Atlanta, Georgia, United States

Hawaii Pacific Health Lihue, Hawaii, United States

Children's Memorial Hospital Chicago, Illinois, United States

View all 17 locations

View Trial Details

Completed

Investigation of Brain Network Dynamics in Depression

NCT01931995

Conditions: Depressive Disorder, Depressive Disorder, Major, Disease Attributes, +6 more
Locations: Martinos Center for Biomedical Imaging/Massachusetts General Hospital Charlestown, Massachusetts, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions